Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | Ccp110 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CCP110 mRNA] | CTD | PMID:31150632 | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CCP110 mRNA | CTD | PMID:22206623 | 17beta-estradiol | affects expression | ISO | CCP110 (Homo sapiens) | 6480464 | Estradiol affects the expression of CCP110 mRNA | CTD | PMID:22574217 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ccp110 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CCP110 mRNA | CTD | PMID:33387578 | 2-methylcholine | affects expression | ISO | CCP110 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of CCP110 mRNA | CTD | PMID:21179406 | 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of CCP110 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | decreases expression | ISO | Ccp110 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of CCP110 mRNA | CTD | PMID:24780913 | aflatoxin B1 | affects expression | ISO | CCP110 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of CCP110 protein | CTD | PMID:20106945 | aflatoxin B1 | decreases methylation | ISO | CCP110 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of CCP110 promoter | CTD | PMID:30157460 | aflatoxin B1 | increases methylation | ISO | CCP110 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of CCP110 gene | CTD | PMID:27153756 | aflatoxin B1 | increases expression | ISO | CCP110 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of CCP110 mRNA | CTD | PMID:22100608 and PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | CCP110 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of CCP110 mRNA | CTD | PMID:33167477 | arsenite(3-) | multiple interactions | ISO | CCP110 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to CCP110 mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | affects methylation | ISO | CCP110 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of CCP110 promoter | CTD | PMID:30157460 | benzo[a]pyrene | increases expression | ISO | CCP110 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of CCP110 mRNA | CTD | PMID:32234424 | benzo[e]pyrene | increases methylation | ISO | CCP110 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of CCP110 promoter | CTD | PMID:30157460 | bisphenol A | affects expression | ISO | Ccp110 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of CCP110 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CCP110 mRNA | CTD | PMID:32156529 | bisphenol A | increases expression | ISO | Ccp110 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of CCP110 mRNA | CTD | PMID:34947998 | bisphenol A | increases methylation | ISO | Ccp110 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of CCP110 gene | CTD | PMID:28505145 | cadmium atom | multiple interactions | ISO | CCP110 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCP110 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | CCP110 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCP110 mRNA | CTD | PMID:35301059 | calcitriol | multiple interactions | ISO | CCP110 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CCP110 mRNA | CTD | PMID:21592394 | calcitriol | decreases expression | ISO | CCP110 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of CCP110 mRNA | CTD | PMID:21592394 | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of CCP110 mRNA | CTD | PMID:37019170 | cisplatin | increases expression | ISO | CCP110 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of CCP110 mRNA | CTD | PMID:27594783 | copper atom | multiple interactions | ISO | CCP110 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of CCP110 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | CCP110 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of CCP110 mRNA | CTD | PMID:20971185 | copper(II) sulfate | increases expression | ISO | CCP110 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of CCP110 mRNA | CTD | PMID:19549813 | coumestrol | multiple interactions | ISO | CCP110 (Homo sapiens) | 6480464 | [Coumestrol co-treated with Resveratrol] results in increased expression of CCP110 mRNA | CTD | PMID:19167446 | Cuprizon | decreases expression | ISO | Ccp110 (Rattus norvegicus) | 6480464 | Cuprizone results in decreased expression of CCP110 mRNA | CTD | PMID:27523638 | cyclosporin A | increases expression | ISO | CCP110 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of CCP110 mRNA | CTD | PMID:20106945 | dioxygen | multiple interactions | EXP | | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCP110 mRNA | CTD | PMID:30529165 | ethanol | affects splicing | EXP | | 6480464 | Ethanol affects the splicing of CCP110 mRNA | CTD | PMID:30319688 | ethyl methanesulfonate | increases expression | ISO | CCP110 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of CCP110 mRNA | CTD | PMID:23649840 | folic acid | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CCP110 mRNA | CTD | PMID:22206623 | folic acid | decreases expression | ISO | CCP110 (Homo sapiens) | 6480464 | Folic Acid results in decreased expression of CCP110 mRNA | CTD | PMID:21867686 | formaldehyde | increases expression | ISO | CCP110 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of CCP110 mRNA | CTD | PMID:23649840 | FR900359 | decreases phosphorylation | ISO | CCP110 (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of CCP110 protein | CTD | PMID:37730182 | gentamycin | decreases expression | ISO | Ccp110 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of CCP110 mRNA | CTD | PMID:33387578 | hydrogen peroxide | multiple interactions | EXP | | 6480464 | [Hydrogen Peroxide co-treated with N-(oxo-5 more ... | CTD | PMID:31494107 | maneb | multiple interactions | EXP | | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of CCP110 mRNA | CTD | PMID:36117858 | methapyrilene | increases methylation | ISO | CCP110 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of CCP110 promoter | CTD | PMID:30157460 | methyl methanesulfonate | increases expression | ISO | CCP110 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of CCP110 mRNA | CTD | PMID:23649840 | oxaliplatin | decreases expression | ISO | Ccp110 (Rattus norvegicus) | 6480464 | Oxaliplatin results in decreased expression of CCP110 mRNA | CTD | PMID:25729387 | oxaliplatin | multiple interactions | ISO | Ccp110 (Rattus norvegicus) | 6480464 | [Oxaliplatin co-treated with Topotecan] results in decreased expression of CCP110 mRNA | CTD | PMID:25729387 | paracetamol | increases expression | ISO | CCP110 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of CCP110 mRNA | CTD | PMID:22230336 | paraquat | multiple interactions | EXP | | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of CCP110 mRNA | CTD | PMID:36117858 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | CCP110 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of CCP110 mRNA | CTD | PMID:27153767 | picoxystrobin | increases expression | ISO | CCP110 (Homo sapiens) | 6480464 | picoxystrobin results in increased expression of CCP110 mRNA | CTD | PMID:33512557 | resveratrol | multiple interactions | ISO | CCP110 (Homo sapiens) | 6480464 | [Coumestrol co-treated with Resveratrol] results in increased expression of CCP110 mRNA | CTD | PMID:19167446 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of CCP110 mRNA | CTD | PMID:36209798 | sodium dichromate | affects expression | ISO | Ccp110 (Rattus norvegicus) | 6480464 | sodium bichromate affects the expression of CCP110 mRNA | CTD | PMID:22110744 | sunitinib | decreases expression | ISO | CCP110 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of CCP110 mRNA | CTD | PMID:31533062 | testosterone | decreases expression | ISO | CCP110 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of CCP110 mRNA | CTD | PMID:21592394 | testosterone | multiple interactions | ISO | CCP110 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CCP110 mRNA | CTD | PMID:21592394 | tetrachloromethane | multiple interactions | ISO | Ccp110 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CCP110 mRNA] | CTD | PMID:31150632 | tetrachloromethane | increases expression | ISO | Ccp110 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of CCP110 mRNA | CTD | PMID:31150632 | thioacetamide | increases expression | ISO | Ccp110 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of CCP110 mRNA | CTD | PMID:34492290 | topotecan | multiple interactions | ISO | Ccp110 (Rattus norvegicus) | 6480464 | [Oxaliplatin co-treated with Topotecan] results in decreased expression of CCP110 mRNA | CTD | PMID:25729387 | tungsten | decreases expression | EXP | | 6480464 | Tungsten results in decreased expression of CCP110 mRNA | CTD | PMID:30912803 | valproic acid | increases expression | ISO | CCP110 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CCP110 mRNA | CTD | PMID:29154799 | vinclozolin | decreases expression | ISO | Ccp110 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of CCP110 mRNA | CTD | PMID:23034163 | |